Connection

Wen-Chun Liu to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Wen-Chun Liu has written about Treatment Outcome.
Wen-Chun Liu
Connection Strength
0.027
Treatment Outcome
  1. Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients. Int J Antimicrob Agents. 2019 Jul; 54(1):35-42.
    View in: PubMed
    Score: 0.007
  2. Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy. World J Gastroenterol. 2018 Feb 14; 24(6):725-736.
    View in: PubMed
    Score: 0.007
  3. Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG. Sci Rep. 2017 05 16; 7(1):1957.
    View in: PubMed
    Score: 0.006
  4. Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection. PLoS One. 2016; 11(12):e0169228.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.